CTOs on the Move

American Pathology Partners

www.ap2.com

 
American Pathology Partners (AP2) company career center! We appreciate your interest in career opportunities with us and encourage you to explore our site to learn more about us and our partner laboratories in Colorado (UniPath), Florida (Palm Beach Pathology), North Carolina (Eastern Carolina Pathology). We are committed to building long-term partnerships within the communities we serve through service excellence and our commitment to the latest in technological innovation. Our pathologist partners are valued leaders within our affiliated laboratories and deliver specialized anatomic and molecular pathology services within their local and regional healthcare markets. As a growing organization, we offer a diversity of ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.ap2.com
  • 103 Continental Place Suite 400
    Brentwood, TN USA 37027
  • Phone: 615.916.3200

Executives

Name Title Contact Details

Similar Companies

New Chapter

New Chapter, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New Chapter, Inc. is based in Brattleboro, VT. You can find more information on New Chapter, Inc. at www.new-chapter.com

Physicians Imaging Solution

Physicians Imaging Solution is a North Canton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Greater Hudson Valley Health

The Greater Hudson Valley Health System is dedicated to developing specialty services, medical programs and needed healthcare services that allow residents to remain close to home to receive quality care.

Sherman Health Systems

Sherman Health Systems is a Elgin, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MSI

MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).